<DOC>
	<DOC>NCT01818297</DOC>
	<brief_summary>The purpose of this study is to assess the safety and efficacy of Subcutaneous Nerve Stimulation (SQS) (also known as Peripheral Nerve Stimulation [PNS]) in the reduction of chronic, intractable post-surgical back pain in adults.</brief_summary>
	<brief_title>Subcutaneous Nerve Stimulation for Failed Back Surgery Syndrome (FBSS) Patients</brief_title>
	<detailed_description>This study is a multi-center, prospective, randomized (1:1) parallel-group design.</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Failed Back Surgery Syndrome</mesh_term>
	<mesh_term>Postoperative Complications</mesh_term>
	<mesh_term>Spinal Diseases</mesh_term>
	<criteria>Key Have persistent back pain for at least 6 months Had back surgery at least 6 months ago Have tried pain medications and physical therapy Read and understand written English or Spanish Male or nonpregnant female. If female of childbearing potential, and if sexually active, must be using a medicallyacceptable method of birth control during study participation Willing and able to undergo surgical implant procedure, attend visits as scheduled, and comply with the study requirements Have an expected lifespan greater than 12 months Key Have leg pain in addition to back pain. Currently enrolled in or plan to enroll in another drug and/or device study Have peripheral vascular disease, peripheral neuropathy, smallfiber neuropathy, or fibromyalgia Have an active systemic infection or are immunocompromised Will be exposed to diathermy or anticipate needing a fullbody MRI scan Currently have an implantable cardiac pacemaker, defibrillator, or neurostimulator Treated with spinal cord stimulation, peripheral nerve stimulation, an intrathecal drug delivery system or requires additional back surgery</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>